Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, ... Read More
-
Surgical Procedures Market by Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Nervous System, Obstetric/Gynecologic), Channel (Physician Offices, Hospitals, ASCs) - US Forecast to 2028
... 1,27,748.5 thousand procedures by 2028 from 1,08,275.5 thousand procedures in 2023, at a CAGR of 3.4% during the forecast period. Growth in the US surgical procedures market is mainly attributed to the rapidly ageing population ... Read More
-
Gastrointestinal OTC Drugs Market by Drug Class (Laxatives, Gastrointestinal Cancer Treatments, Gastric Acid Reducers, Anti-Diarrheal, Proton Pump Inhibitors, H2 Inhibitors, Gastric Acid Neutralizers, Bowel Anti-Inflammatory, Anti-Emetics), Indication (Ga
... Motion Sickness, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028 The global gastrointestinal OTC drugs market size reached US$ 40 Billion in 2022. Looking forward, IMARC Group expects the market to reach ... Read More
-
Global Carcinoid Syndrome Diarrhea Treatment Market - 2023-2030
... by 2030. The global carcinoid syndrome diarrhea treatment market is expected to exhibit a CAGR of 9.8% during the forecast period (2023-2030). Carcinoid syndrome diarrhea is a chronic condition that requires ongoing management and treatment ... Read More
-
Global Digestive & Intestinal Remedies Market Size study & Forecast, by Type (Digestive Medicines, Gastrointestinal Agents, and Remedies), by Age Group (Pediatric, Adult), by Distribution Channel (Online, Offline) and Regional Analysis, 2023-2030
... Intestinal Remedies Market is valued at approximately USD 18.5 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 3.5% over the forecast period 2023-2030. Digestive remedies are treatments ... Read More
-
Colorectal Procedure Market Forecast to 2028 - Global Analysis by Product (Endoscope, Electrosurgery, Handheld Device & Visual Systems, Sealing & Stapling Devices, Ligation Clips & Dilators & Speculas, Cutter & Shears, Accessories, and Others), Surgery Type [Right Hemicolectomy, Left Hemicolectomy, Subtotal Hemicolectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others (Including Endoscopic Surgery)], Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Others), End User (Hospital & Clinics, Surgery Centers, and Others)
... Type [Right Hemicolectomy, Left Hemicolectomy, Subtotal Hemicolectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others (Including Endoscopic Surgery)], Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Others), End User (Hospital & Clinics, ... Read More
-
Colorectal Procedure Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Endoscope, Electrosurgery, Handheld Device & Visual Systems, Sealing & Stapling Devices, Ligation Clips & Dilators & Speculas, Cutter & Shears, Accessories, and Others), Surgery Type [Right Hemicolectomy, Left Hemicolectomy, Subtotal Hemicolectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others (Including Endoscopic Surgery)], Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Others), End User (Hospital & Clinics, Surgery Centers, and Others)
... and Others), Surgery Type [Right Hemicolectomy, Left Hemicolectomy, Subtotal Hemicolectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others (Including Endoscopic Surgery)], Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Others), End User ... Read More
-
Global Gastrointestinal Cytology Brush Market Growth 2023-2029
... CAGR of % from 2023 to 2029. The main consumer markets of Gastrointestinal Cytology Brush are in North America and Asia Pacific. With the gradual recovery of the global economy after the COVID-19 outbreak and ... Read More
-
US Helicobacter Pylori Non-Invasive Testing Market Forecast to 2028 - Country Analysis By Test Type (Urea Breath, Test Method, and Serology), Test Method (Laboratories Based and Point of Care), and End User (Hospitals, Reference Laboratories, and Others)
... and Others) The US Helicobacter Pylori Non-Invasive Testing Market size is expected to grow from US$ 223.76 million in 2022 to US$ 302.79 million by 2028; it is estimated to record a CAGR of 5.3% ... Read More
-
US Helicobacter Pylori Non-Invasive Testing Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Test Type (Urea Breath, Test Method, and Serology), Test Method (Laboratories Based and Point of Care), and End User (Hospitals, Reference Laboratories, and Others)
... (Hospitals, Reference Laboratories, and Others) The US Helicobacter Pylori Non-Invasive Testing Market size is expected to grow from US$ 223.76 million in 2022 to US$ 302.79 million by 2028; it is estimated to record a ... Read More
-
Global Small Molecule Drug Discovery Market by Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification, and Lead Optimization), Regional Forecasts 2021-2027
... Forecasts 2021-2027 Global Small Molecule Drug Discovery Market is valued approximately at USD 32.15 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.05% over the forecast period ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 300 million prevalent cases of GERD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The marketed drugs space for GERD comprises both novel class of potassium-competitive acid blockers (P-CABs) and ... Read More
-
Gastrointestinal Drugs Market Covering Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrhoeals; Global Summary 2023
... In terms of per capita consumption, the market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and ... Read More
-
Pharmaceuticals Market Covering Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs; Vaccines; Therapeutic Nutrients & Minerals; Substance Abuse And Addiction; Global Summary 2023
... & Minerals; Substance Abuse And Addiction; Global Summary 2023 Global pharmaceuticals market was worth $1596.4 billion in 2022. In terms of per capita consumption, the market was $204.6 and in terms of global GDP, the ... Read More
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT) - Global Forecast to 2029
... 1.7 billion by 2029 from USD 0.3 billion in 2023, at a CAGR of 36.1% during the forecast period. The key factors driving the growth of the human microbiome market are the surging demand for ... Read More
-
2023 Global: Gastrointestinal / Gi Stent Market - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 94,000 diagnosed prevalent cases of SBS in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Glucagon-like peptide 2 receptor agonists play a key role in the current treatment paradigm for SBS. R&D activity ... Read More
-
Global Embolotherapy Market Size study & Forecast, by Product (Embolic Agents, Support Devices) by Procedure (Transcatheter Arterial Embolization (TAE), Selective Internal Radiation Therapy (SIRT), Trans arterial Chemoembolization (TACE)), by Disease indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological, Nephrological Disorders, Gastrointestinal Disorders), by End user (Hospitals, Clinics, Ambulatory Surgery Centers, Others) and Regional Analysis, 2022-2029
... Neurological Diseases, Urological, Nephrological Disorders, Gastrointestinal Disorders), by End user (Hospitals, Clinics, Ambulatory Surgery Centers, Others) and Regional Analysis, 2022-2029 Global Embolotherapy Market is valued approximately at USD XX billion in 2021 and is anticipated ... Read More
-
Global Gastrointestinal OTC Drugs Market 2023-2027
... gastrointestinal OTC drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Upper Gastrointestinal Capsule Endoscopy Market Growth 2023-2029
... to grow at a CAGR of 16.9% from 2023 to 2029. United States market for Upper Gastrointestinal Capsule Endoscopy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Gastrointestinal Wireless Detection System Market Growth 2023-2029
... at a CAGR of % from 2023 to 2029. United States market for Gastrointestinal Wireless Detection System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of ... Read More
-
Global Gastrointestinal Capsule Endoscopy Market Growth 2023-2029
... CAGR of % from 2023 to 2029. United States market for Gastrointestinal Capsule Endoscopy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Global Intelligent Capsule Gastrointestinal Endoscopy System Market Growth 2023-2029
... is expected to grow at a CAGR of 19.1% from 2023 to 2029. United States market for Intelligent Capsule Gastrointestinal Endoscopy System is estimated to increase from US$ million in 2022 to US$ million by ... Read More
-
Point of Care Molecular Diagnostics Market: By Product and Service (Assays & Kits, Instruments & Analyzers, Software & Services), By Technology (RT-PCR, INAAT, Other Technologies), By Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infections, Cancer, Hepatitis, Gastrointestinal Disorders, Other Applications), By End-User (Physicians’ Offices, Hospitals & ICUs, Research Institutes, Other End Users) And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
... Hepatitis, Gastrointestinal Disorders, Other Applications), By End-User (Physicians’ Offices, Hospitals & ICUs, Research Institutes, Other End Users) And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031 Point ... Read More
-
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Inflammatory Bowel Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. Report includes an overview of trial numbers and ... Read More
Research Assistance
